期刊文献+

流感病毒多表位基因盒的设计与预测 被引量:1

Design and prediction of multi-epitope gene of influenza A virus
原文传递
导出
摘要 目的预测流感病毒抗原表位并设计合成多表位基因盒。方法收集不同类型流感病毒基因序列,联合运用Syf-peithi、ProPred、Multipred2、Bcepred、Clastal X1.83、SWISS-MODEL等多种生物信息学软件进行分析,预测流感病毒Matrix1(M1)、Matrix2(M2)、Nucleoprotein(NP)和HA蛋白上的抗原表位,设计并合成流感病毒多表位基因盒。结果在不同亚型流感病毒的HA蛋白抗原上成功筛选出2个B细胞表位,在M1、M2及NP蛋白上分别筛选出3个T细胞表位,以一定的间隔序列串联各表位,设计并合成流感多表位基因盒。预测结果显示该多表位基因盒具有良好的同源性及抗原性。结论成功设计出包含T细胞表位及B细胞表位的流感病毒多表位基因盒Eg,为流感多表位基因疫苗的研发奠定了基础。 OBJECTIVE To design and predict multi-epitope gene of influenza A virus.METHODS Different gene sequences of current popular influenza A virus were searched.The epitopes on Matrix1protein(M1),Matrix2 protein(M2),Nucleoprotein(NP) and Hemagglutinin(HA) were analyzed and screened using bioinformatics programs such as Syfpeithi,ProPred,Multipred2,Bcepred,Clastal X1.83 and SWISS-MODEL.The multi-epitope gene of influenza A virus was designed and synthesized by series connection.RESULTS Two B cell epitopes on HA and three T cell epitopes on M1,M2 or NP were screened and multi-epitope gene of influenza A virus was designed successfully.Prediction of epitope showed that the multi-epitope gene had better homology and antigenicity,and could keep better biologicalactivity after incised by protease.CONCLUSION The Multi-epitope gene combined with T cell epitopes and B cell epitopes,has been successfully prepared and lays the foundation for further study on the multi-epitope gene vaccine against influenza A virus.
出处 《华西药学杂志》 CAS CSCD 北大核心 2012年第5期486-489,共4页 West China Journal of Pharmaceutical Sciences
基金 国家自然科学基金(批准号:30973235) 四川省科技支撑项目(批准号:2010SZ0110)
关键词 流感病毒 抗原表位 生物信息学分析 多表位基因盒 Influenza A virus Epitope Bioinformatics analyse Multi-epitope gene
  • 相关文献

参考文献16

  • 1Zhong W, Chem JB. Genome - wide characterization of a viral cy- totoxic T lymphocyte epitope repertoire [ J ]. J Biol Chem,2003, 278:45135 -45144.
  • 2Crowe SR, Miller SC, Brown DM,et al. Uneven distribution of MHC classII epitopes within the in uenza virus [ J ]. Vaccine , 2006,24:457 - 467.
  • 3Li H,Ding J,Chen YH. Recombinant protein comprising multi - neutralizing epitopes induced high titer of antibodies against influ- enza A virus [ J ]. Immunobiology ,2003 ,207 :305 - 313.
  • 4Lu Y, Ding J, Liu W,et al. A candidate vaccine against influenza virus intensively improved the immunogenicity of a neutralizing epitope [ J ]. Int Arch Allergy Immunol,2002,127:245 - 250.
  • 5Deliyannis G, Jackson DC, Ede N J, et al. Induction of long- term memory CD8( + ) T cells for recall of viral clearing responses a- gainst influenza virus[ J]. J Virol ,2002,76:4212 -4221.
  • 6Lawrence CW, Ream RM, Braciale TJ. Frequency, specificity, and sites of expansion of CD8 + T cells during primary pulmonary in- fluenza virus infection [ J ]. J Immuno1,2005 ,174 :5332 - 5440.
  • 7Berkhoff EGM, Geelhoed - Mierss MM, Fouchier RAM, et aJ. Assessment of the extent of variation in influenza A virus cytotoxic T - lymphocyte epitopes by using virus - specific CD8 + T - cell clones[J]. J Gen Viro1,2007 ,88 :530 - 535.
  • 8Kreijtz JHCM, Bodewes R, Brand JMA, et al. Infection of mice with a human influenza A/H3N2 virus induces protective immu- nity against lethal infection with influenza A/H5N1 virus [J]. Vaccine ,2009,27:4983 - 4989.
  • 9Khan N,Hislop A,Gudgeon N,et al. Herpesvims- specific CD8 T cell immunity in old age:Cytomegalovirus impairs the response to a coresident EBV infection [ J ], J Immunol,2004,173 (12) : 7481 - 7489.
  • 10Toebes M, Coccoris M, Bins A,et al. Design and use of condi- tional MHC class I ligands[ J]. Nat Med,2006,12:246- 251.

二级参考文献28

共引文献9

同被引文献17

  • 1Meng S, I: Z. , Xu L, et al. Intranasal immunization with re- combinant HA and mast cell activator C48/80 elicits protective immunity against 2009 pandemic H1N1 influenza in mice [J]. PLoS One, 2011, 6(5)z e19863.
  • 2Ferraris O, E. V. , Bouscambert M, et al. H1N1 influenza A virus neuraminidase modulates infectivity in mice [J]. Antiviral Res, 2012, 93(3); 374 380.
  • 3Imai M, Watanabe T, Hatta M, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets [J]. Nature, 2012, 486(7403) ; 420 428.
  • 4Seasonal influenza World Health Organization, Copenhagen, Denmark (2009). (www. euro. who. int/influenza/2008618 1).
  • 5Girard MP, Cherian T, Pervikov Y, et al. A review of vaccine research and development: human acute respiratory infections [J]. Vaccine, 2005, 23 (50): 5708-5724.
  • 6Alarcon JB, Waine GW, McManus DP. DNA vaccines: technol- ogy and application as anti-parasite and anti microbial agents[J]. Adv Parasitol, 1999, 42: 343-410.
  • 7Kishwar Hayat Khan. DNA vaccine: roles against diseases [J]. Germs, 2013, (3)1: 27-35.
  • 8Graeme E. Price, Chia-Yun Lo, et al. Mucosal Immunization with a Candidate Universal Influenza Vaccine Reduces Virus Transmission in a Mouse Model [J]. Journal of Virology, 2014, 88(11) : 6019-6030.
  • 9Donnelly JJ, Friedman A, Ulmer JB, et al. Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination[J]. Vaccine, 1997, 15(8): 865-868.
  • 10Chen Q, Kuang H, Wang H, et al. Comparing the ability of a series of viral proteinexpressing p[asmid DNAs to protect against H5NJ influenza virus[J] Virus Genes, 2009, 38(1): 30-38.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部